Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012

DANBURY, Conn., March 8, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Errol De Souza, President and CEO of Biodel, will present a corporate update at the ROTH 24th Annual OC Growth Stock Conference on ­­­­­­­­­March 14, 2012 at 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time).

The ROTH 24th Annual OC Growth Stock Conference will be held March 11-14, 2012, at the Ritz Carlton Hotel in Laguna Niguel, California.

Interested parties may access the presentation in the investor relations section of Biodel's website at www.biodel.com which will link to a live webcast to be archived for 60 days.

About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients.  We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.  For further information regarding Biodel, please visit the company's website at www.biodel.com.

BIOD-G

CONTACT: Seth Lewis, +1-646-378-2952

SOURCE Biodel Inc.